These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
657 related articles for article (PubMed ID: 32330311)
1. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma. Zhang Y; Zhang L; Xu Y; Wu X; Zhou Y; Mo J J Cell Physiol; 2020 Dec; 235(12):9304-9316. PubMed ID: 32330311 [TBL] [Abstract][Full Text] [Related]
2. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma. Xu Q; Wang Y; Huang W Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322 [TBL] [Abstract][Full Text] [Related]
3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
5. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
6. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
7. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
8. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L; Xie R; Lu G Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555 [TBL] [Abstract][Full Text] [Related]
9. A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients. Jiang H; Zhao L; Chen Y; Sun L J Clin Lab Anal; 2020 Sep; 34(9):e23377. PubMed ID: 32474975 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients. Bai Z; Li H; Li C; Sheng C; Zhao X Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma. Yuan M; Wang Y; Sun Q; Liu S; Xian S; Dai F; Zhang L; Fan Y; Wang F; Yang D; Zheng Y; Deng Z; Tan W; Liu Y; Cheng Y Biomed Res Int; 2021; 2021():9798231. PubMed ID: 33506049 [TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks. Zhao X; Bai Z; Li C; Sheng C; Li H Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578 [TBL] [Abstract][Full Text] [Related]
13. Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma. Huang F; Zhang C; Yang W; Zhou Y; Yang Y; Yang X; Guo W; Wang B BMC Genomics; 2024 Feb; 25(1):155. PubMed ID: 38326754 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma. Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma. Liu C; Wu S; Lai L; Liu J; Guo Z; Ye Z; Chen X BMC Bioinformatics; 2023 Jan; 24(1):4. PubMed ID: 36597032 [TBL] [Abstract][Full Text] [Related]
16. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma. Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056 [TBL] [Abstract][Full Text] [Related]
17. Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma. Li R; Jin C; Zhao W; Liang R; Xiong H BMC Gastroenterol; 2022 Nov; 22(1):450. PubMed ID: 36344926 [TBL] [Abstract][Full Text] [Related]
18. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233 [TBL] [Abstract][Full Text] [Related]
19. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks. Yu X; Zhang J; Yang R; Li C Biomed Res Int; 2020; 2020():8579651. PubMed ID: 33299877 [TBL] [Abstract][Full Text] [Related]
20. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma. Ma Y; Luo T; Dong D; Wu X; Wang Y Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]